Skip to main content
TNYA
NASDAQ Life Sciences

10% Stockholder Files Intent to Sell Over $500K in Shares Amidst Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.701
Mkt Cap
$147.159M
52W Low
$0.36
52W High
$2.35
52W Position info
95% above low
Off High info
70% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

TNYA sits 95% above its 52-week low of $0.36 on elevated volume (2.0× avg).

Summary

A significant 10% stockholder, COLUMN GROUP III-A, LP, has filed a Form 144 indicating intent to sell an additional $504,788 worth of Tenaya Therapeutics common stock, following recent sales and a Nasdaq delisting notice.


Key Events · Ownership and Investor Activity · TNYA

  • Major Shareholder Intent to Sell

    COLUMN GROUP III-A, LP, a 10% stockholder, intends to sell 742,663 shares of common stock, valued at approximately $504,788.

  • Recent Selling Activity

    This follows the sale of 182,295 shares by the same filer on February 10, 2026, generating gross proceeds of $148,770.95.

  • Context of Delisting Notice

    The selling activity occurs shortly after Tenaya Therapeutics received a Nasdaq delisting notice on January 30, 2026, for failing to meet the minimum bid price requirement.


Analysis · TNYA · Life Sciences

This Form 144 filing signals a continued reduction in stake by a major institutional investor, COLUMN GROUP III-A, LP. The proposed sale of over $500,000 in shares, combined with previous sales reported in the last three months, indicates a sustained divestment. This activity is particularly notable given the company's recent receipt of a Nasdaq delisting notice on January 30, 2026, which raises concerns about the company's financial stability and future prospects. The repeated selling by a significant shareholder during a period of corporate distress could further pressure the stock.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TNYA was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $147.2M. The 52-week trading range was $0.36 to $2.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TNYA - Latest Insights

TNYA
Nov 04, 2026, 4:41 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.377
Real-time Price: $0.2944 info
Change: -$0.0826 (-22%) info
Market Cap: $66.874M info
TNYA
Nov 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.385
Real-time Price: $0.2944 info
Change: -$0.0906 (-24%) info
Market Cap: $66.874M info
TNYA
Oct 13, 2026, 4:42 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.530
Real-time Price: $0.2944 info
Change: -$0.2356 (-44%) info
Market Cap: $66.874M info
TNYA
Sep 14, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.6395
Real-time Price: $0.2944 info
Change: -$0.3451 (-54%) info
Market Cap: $66.874M info
TNYA
Aug 05, 2026, 4:46 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.7497
Real-time Price: $0.2944 info
Change: -$0.4553 (-61%) info
Market Cap: $66.874M info